Results 51 to 60 of about 1,928,648 (313)
Background Stigma emerged as a prominent public health challenge in the global mpox outbreak that began in 2022, impeding outbreak control efforts and the well-being of affected individuals.
Amy Paterson +10 more
doaj +1 more source
ABSTRACT Background Managing long COVID in people with multiple sclerosis and related disorders (pwMSRD) is complex due to overlapping symptoms. To address evidence gaps, we evaluated long COVID susceptibility in pwMSRD versus controls and its associations with multi‐domain function and disability.
Chen Hu +15 more
wiley +1 more source
Hantavirus Infection: a review and global update
Hantaviruses have the potential to cause two different types of diseases in human: hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS).
Zhenqiang Bi +2 more
doaj +1 more source
Job Insecurity in the COVID-19 Pandemic on Counterproductive Work Behavior of Millennials: A Time-Lagged Mediated and Moderated Model [PDF]
Fei Yiwen, Juhee Hahn
openalex +1 more source
Accelerated Progression of Gait Impairment in Parkinson's Disease and REM Sleep Without Atonia
ABSTRACT Objective People with Parkinson's disease (PD) and rapid eye movement (REM) sleep without atonia (RSWA) often have more severe gait disturbances compared to PD without RSWA. The association between the presence and expression of RSWA and the rate of progression of gait impairment in PD is unknown.
Sommer L. Amundsen‐Huffmaster +11 more
wiley +1 more source
Efficacy of baloxavir marboxil against bovine H5N1 virus in mice
Since the first detection of highly pathogenic avian influenza (HPAI) H5N1 (clade 2.3.4.4b) in U.S. dairy cattle in early 2024, the virus has spread rapidly, posing a major public health concern as the number of human cases continues to rise.
Maki Kiso +3 more
doaj +1 more source
Traumatic brain injury during COVID-19 pandemic—time-series analysis of a natural experiment [PDF]
Banu Manickam Rajalu +8 more
openalex +1 more source
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund +3 more
wiley +1 more source
“Pandemic fear” and COVID-19: mental health burden and strategies
‘‘Pandemic fear’’ and COVID-19: mental health burden and strategies Felipe Ornell,0000-0001-8638-5842 Jaqueline B. Schuch,0000-0001-8638-5842 Anne O. Sordi,0000-0001-8638-5842 Felix Henrique Paim Kessler0000-0001-8638-5842 Centro de Pesquisa em Álcool e ...
F. Ornell +3 more
semanticscholar +1 more source
The Pandemic Influenza Preparedness (PIP) Framework Partnership Contribution Scheme has enabled countries to further strengthen their preparedness capacities in the areas of laboratory and surveillance, burden of disease estimation, regulatory capacity ...
Hitesh Chugh +5 more
doaj +1 more source

